Opana ER

The Food and Drug Administration requested drug maker Endo Pharmaceuticals stop selling Opana ER, which is an opioid. NPR's Robert Siegel speaks with Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, about the decision.